NEW YORK (GenomeWeb News) - Norwegian company Genpoint has merged with Swedish firm MBS, the companies said today in a joint release.
 
The companies market DNA-analysis instruments and reagents for clinical diagnostics that have been used for tuberculosis, staph infections, and sexually transmitted diseases.
 
Erik Hornes, Genpoint's CEO, said the combined companies will continue to work on bacterial infections and will also shift to viral infections and cancer.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.